10.1002/ajhb.1310050603 58 HermansenK.BengtsenM.KjrM.VestergaardP.JrgensenJ
This is normal variation in individual response
(Practice point) Once an SGLT2i is initiated, it is reasonable to continue an SGLT2i even if the eGFR falls below 30 ml/min per 1.73 m2, unless it is not tolerated or kidney replacement therapy is initiated.(Practice point) SGLT2i have not been adequately studied in kidney transplant recipients, who may benefit from SGLT2i treatment, but are immunosuppressed and potentially at increased risk for infections
The risk is lower when combined with metformin alone
Lactate, pyruvate, and acetate reduce epithelial cell adherence and invasion, likely due to altered capsule biosynthesis and adhesin expression
Melanotan 2 acts inside the body through hormonal pathways, unlike topical bronzers or spray tanning products